Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
CS1 plus BCMA CAR-T by BioSeedin for Multiple Myeloma (Kahler Disease): Likelihood of Approval
CS1 plus BCMA CAR-T is under clinical development by BioSeedin and currently in Phase I for Multiple Myeloma (Kahler Disease)....